SentiAR
Private Company
Total funding raised: $11M
Overview
SentiAR is a privately-held digital health company founded in 2016 and headquartered in St. Louis, Missouri. The company has developed a proprietary augmented reality software platform that projects interactive, real-time 3D holograms of patient anatomy and medical device data into a physician's field of view during procedures. Its initial commercial focus is the cardiac electrophysiology (EP) ablation market with the CommandEP system, which integrates with existing catheter mapping systems. SentiAR represents a novel approach to intra-procedural visualization, seeking to reduce complexity and improve outcomes in fast-growing minimally invasive surgical fields.
Technology Platform
Proprietary software platform that creates real-time, interactive 3D holograms from live medical device data (e.g., electroanatomic mapping systems, catheter sensors) for visualization via augmented/mixed reality headsets during interventional procedures.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
SentiAR is a pioneer in holographic AR for procedural guidance. Direct competitors are likely other AR/VR surgical navigation startups. Indirect competitors include major EP mapping system vendors (Abbott, Boston Scientific) who could develop similar features, and traditional 2D/3D display monitor companies.